.Merck trumps incomes requirements, brings up purchases expectation on powerful need for best drugs like Keytruda CNBCMerck & Co. (MRK United States) Trumps Earnings Forecasts as Keytruda Sales Growth BloombergMerck Sell: Pharma Titan Posts Solid End Results, But Expectation Drops Short Capitalist's Company DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck beats earnings and also purchases desires in the middle of Keytruda strength, however supplies blended full-year overview MarketWatch.